Korecyte Bio presented its ambitions for CAR-T against solid tumours during the premier Charles River’s European Cell & Gene Therapy Summit 2024 event held in the world’s biggest biotech hub, and this time in London. The event brought together leading experts, executives, and thought leaders in the CGT space to discuss and navigate critical challenges, including the patient’s journey by sharing the story of a young patient that was cured by CAR-T therapy.
CRL’s CGT Summit 2024
